Cryosite Limited
Research Cryosite Limited (CTE.AX) on Bullrun: market cap AUD 58.82M, P/E 30.1. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerCTE.AX
- ExchangeAU
- CountryAustralia
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyAUD
- Market capAUD 58.82M
- P/E30.1
- Financial periodFY2026
- RevenueAUD 16.70M
- Revenue growth18.3%
- Net incomeAUD 2.24M
- Free cash flow-AUD 8.05M
- Gross margin62.4%
Valuation Snapshot
latest market cap is AUD 58.82M; P/E is 30.1.
Peer valuation comparison
Latest P/E is 30.13x versus a Healthcare sector median of 24.73x (21.8% above).
Latest P/E is 30.13x versus a Australia median of 15.06x (100.1% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | AUD 16.70M | AUD 2.24M | -AUD 8.05M | 62.4% | n/a | AUD 2.24M | AUD 7.72M | AUD 4.85M |
| FY2025 | AUD 14.12M | AUD 1.88M | AUD 1.48M | 63.0% | 0.04 | AUD 5.06M | AUD 2.27M | AUD 2.39M |
| FY2024 | AUD 12.61M | AUD 1.84M | AUD 2.29M | 63.4% | 0.04 | AUD 4.70M | AUD 2.45M | AUD 1.45M |
| FY2023 | AUD 11.94M | AUD 1.41M | AUD 1.11M | 60.1% | 0.03 | AUD 5.73M | AUD 2.61M | AUD 2.78M |
| FY2022 | n/a | n/a | n/a | n/a | 0.03 | n/a | n/a | n/a |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-17 | AUD 58.82M | 30.1 | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 AUD.
| Year | Dividends/share |
|---|---|
| FY2024 | 0.07 AUD |
| FY2023 | 0.02 AUD |
| FY2022 | 0.01 AUD |
About Cryosite Limited
Cryosite Limited provides outsourced clinical trials logistic services in Australia. It operates through Ambient, cold, and frozen; Ultra-frozen and cryogenic; and Cord Blood segments. The Ambient, cold, and frozen segment provides good manufacturing practice (GMP) clinical trial materials, scheduled medicines, controlled drug storage, clinical ancillary supplies, medical devices, and commercial products with strict temperature requirements.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Cryosite Limited's market cap?
Cryosite Limited's market capitalization is AUD 58.82M.
What is Cryosite Limited's P/E ratio?
Cryosite Limited's price-to-earnings (P/E) ratio is 30.1.
What does Cryosite Limited do?
Cryosite Limited provides outsourced clinical trials logistic services in Australia. It operates through Ambient, cold, and frozen; Ultra-frozen and cryogenic; and Cord Blood segments. The Ambient, cold, and frozen segment provides good manufacturing practice (GMP) clinical trial materials, scheduled medicines, controlled drug storage, clinical ancillary supplies, medical devices, and commercial products with strict temperature requirements.